+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dysphagia Management Market - Global Forecast to 2030- Product Image
Dysphagia Management Market - Global Forecast to 2030- Product Image
Sale

Dysphagia Management Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887605
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dysphagia Management Market grew from USD 3.32 billion in 2024 to USD 3.52 billion in 2025. It is expected to continue growing at a CAGR of 5.78%, reaching USD 4.66 billion by 2030.

Dysphagia management occupies a critical intersection of nutrition, therapy, and medical device innovation to address the complex challenges of impaired swallowing. As patient populations age and comorbidities such as stroke, dementia, and cancer become more prevalent, healthcare systems face mounting pressure to deliver safe, effective, and patient‐centered interventions. New diagnostic tools, advances in digital therapeutics, and evolving care protocols have rapidly altered clinical pathways and home‐based care strategies.

Healthcare providers now integrate multidisciplinary teams that include speech‐language pathologists, dietitians, gastroenterologists, and rehabilitation specialists to optimize swallowing therapy and nutritional support. Recent years have witnessed heightened interest in minimally invasive enteral feeding technologies, next‐generation thickening agents, and tailored soft food formulations. Simultaneously, digital solutions such as mobile applications and wearable sensors enable real‐time monitoring, remote assessment, and personalized therapy adjustments.

In this dynamic environment, industry stakeholders must anticipate emerging trends, regulatory shifts, and economic headwinds to align product development, supply chain strategies, and market access initiatives. This executive summary delivers a concise, evidence‐based overview of the transformative shifts, tariff impacts, segmentation insights, regional dynamics, leading players, and actionable recommendations shaping the dysphagia management market today.

Transformative Shifts Reshaping Dysphagia Management

The dysphagia care paradigm is undergoing profound transformation driven by technological breakthroughs, shifting care delivery models, and evolving patient expectations. First, the convergence of digital therapeutics with conventional rehabilitation has redefined treatment adherence and outcome measurement. Mobile applications now guide patients through swallow exercises, while wearable devices track real‐time improvements in swallowing biomechanics.

Second, personalized nutrition has advanced beyond texture modification to molecularly tailored soft foods and precision‐engineered thickening agents. Innovations in starch‐ and gum‐based formulations address safety and sensory acceptance, reducing the risk of aspiration and improving quality of life.

Third, care delivery is decentralizing as home healthcare settings expand capacity and capabilities. Remote monitoring solutions and telepractice empower clinicians to extend therapy beyond hospital walls, optimizing resource utilization and patient convenience.

Finally, regulatory frameworks are adapting to novel digital and nutritional interventions, creating pathways for accelerated approvals while ensuring robust safety standards. In combination, these shifts are setting a new trajectory for dysphagia management, one where patient engagement, data‐driven decision making, and integrated care pathways converge to drive superior outcomes.

Assessing the Cumulative Impact of United States Tariffs in 2025

The imposition of new United States tariffs in 2025 has introduced layered complexities for enterprises operating within the dysphagia management ecosystem. These levies affect both raw materials and finished goods used in feeding tubes, soft foods, and thickening agent manufacturing. As a result, procurement teams face higher input costs for critical components such as polymer tubing, specialized starches, and medical‐grade packaging.

Supply chain managers are responding by diversifying sourcing, near‐shoring key manufacturing activities, and renegotiating contracts to mitigate margin erosion. Concurrently, regulatory affairs leaders are monitoring tariff classification codes to ensure compliance and capitalize on potential exemptions. While some companies have absorbed incremental costs, others are strategically repositioning product portfolios to emphasize high‐value therapeutic approaches that can justify modest price increases.

Moreover, cross‐border collaborations between U.S. and international stakeholders are intensifying, with joint ventures and licensing agreements designed to navigate complex trade environments. As stakeholders adapt to this evolving tariff landscape, resilience will hinge on agile supply chain networks, dynamic pricing strategies, and robust scenario planning.

Key Insights from Multi-Dimensional Market Segmentation

A multi‐dimensional view of the dysphagia management market reveals nuanced opportunities and challenges. When analyzing by product type, the landscape encompasses enteral feeding systems-specifically gastrostomy tubes and nasogastric tubes-alongside soft foods categorized as mechanical soft diets and purees. The thickening agents segment further subdivides into ready‐to‐drink formulations and powdered thickeners, the latter comprising gum‐based and starch‐based varieties. Each subcategory exhibits distinct regulatory requirements, manufacturing complexity, and end‐user adoption patterns.

Demographic segmentation highlights divergent needs among adults, geriatrics, and pediatrics. Within the older adult cohort, dependent and independent subgroups differ in care intensity and nutritional support requirements, whereas the pediatric segment spans infants to teenagers, demanding highly flexible formulations and delivery methods.

Disease‐based differentiation separates mechanical dysphagia arising from surgical interventions or oncological treatments from neurological dysphagia linked to dementia or stroke. Mechanical cases often require immediate enteral support, while neurological presentations benefit from integrated rehabilitative and compensatory therapies.

End‐user analysis spans home healthcare settings, hospitals-both private and public-and long‐term care facilities, including nursing homes and rehabilitation centers. Each environment influences product selection, clinician workflow, and reimbursement pathways.

Therapeutic approaches split between compensatory techniques, such as bolus control and posture modifications, and restorative techniques like sensory stimulation and structured swallowing exercises. Finally, distribution channels range from hospital pharmacies to retail pharmacies-chain and independent outlets-as well as online sales platforms. Layered atop these segments is the emergence of digital therapeutics, covering mobile applications and wearable devices, alongside non‐digital manual swallow aids.

Regional Dynamics Driving Growth and Innovation

Geographic analysis underscores the Americas as a hub for innovation in enteral feeding technology, supported by strong reimbursement frameworks and a burgeoning home healthcare infrastructure. In contrast, the Europe, Middle East & Africa region demonstrates varied adoption driven by differing healthcare budgets and regulatory landscapes; advanced economies in Western Europe lead in digital therapeutics integration, while emerging markets prioritize cost‐effective nutritional solutions.

Meanwhile, the Asia‐Pacific region is experiencing accelerated growth propelled by expanding geriatric populations, rising incidence of neurological disorders, and increased investment in healthcare modernization. Key markets such as Japan and Australia showcase early adoption of next‐generation thickening agents, whereas rapidly developing markets in Southeast Asia present untapped potential for telepractice and remote monitoring devices. Overall, regional dynamics reveal that customization to local clinical protocols, partnered with targeted commercialization strategies, remains critical to capturing market share.

Competitive Landscape and Leading Players

The competitive environment is defined by a diverse mix of global pharmaceutical giants, specialized device manufacturers, nutritional experts, and emerging digital health innovators. Abbott Laboratories leverages its broad nutraceutical portfolio to deliver advanced thickening solutions, while AstraZeneca PLC and F. Hoffmann-La Roche AG bring robust R&D capabilities to the development of novel diagnostic and therapeutic agents.

Within medical devices, Becton, Dickinson and Company and Cook Group Incorporated stand out for their comprehensive feeding tube offerings, encompassing both gastrostomy and nasogastric systems. Bracco Diagnostics Inc. distinguishes itself with imaging agents that enhance swallowing assessments.

Nutritional market leaders Danone S.A. and Nestlé S.A. drive innovation in soft foods, collaborating with academic partners to refine puree textures and nutrient profiles. Ingredion Incorporated and International Flavors & Fragrances Inc. focus on sensory science to optimize gum-based and starch-based thickening agents, while Flavour Creations fine-tunes taste masking and mouthfeel.

Pharmaceutical companies Cipla Limited, Dr. Reddy’s Laboratories Ltd., Deosen Biochemical (Ordos) Ltd., and Novartis AG enhance product portfolios through licensing and co‐development partnerships targeting dysphagia‐related complications. Device innovators such as Phagenesis Ltd. and VitalStim UK Ltd. pioneer neurostimulation and swallowing exercise platforms.

Meanwhile, Medline Industries, LP, Johnson & Johnson Services, Inc., and Fresenius Kabi AG integrate distribution, manufacturing, and service capabilities to offer end-to-end solutions. Producers like Hormel Foods Corporation, Kent Precision Foods Group, Inc., Rosemont Pharmaceuticals Limited, and Slo Drinks experiment with customized texture modification and packaging solutions for patient convenience.

Actionable Recommendations for Industry Leadership

To thrive in the evolving dysphagia management market, industry leaders should prioritize strategic partnerships, harness digital innovation, and optimize supply chains. First, forging alliances between device manufacturers and digital therapeutics firms can accelerate integrated solution offerings, enabling seamless transitions between clinical settings and home care.

Second, investing in modular manufacturing capabilities for thickening agents and soft foods allows rapid reformulation to meet patient‐specific requirements, regulatory changes, and tariff adjustments. Third, establishing centers of excellence that unite speech‐language pathologists, dietitians, and data scientists will facilitate evidence‐based protocols and drive superior patient outcomes.

Fourth, companies should conduct comprehensive tariff and trade compliance reviews while implementing dual‐sourcing strategies to mitigate cost fluctuations. Fifth, embracing remote monitoring platforms and telepractice models will expand market reach and enhance care continuity. Finally, proactive engagement with health technology assessment bodies and reimbursement authorities will ensure favorable coverage of innovative therapies, fostering sustainable market growth.

Conclusion: Charting the Path Forward

The dysphagia management sector stands at a critical juncture where innovation, regulation, and patient‐centric care converge. Leaders who anticipate emerging shifts, leverage cross‐sector collaborations, and embrace digital and therapeutic integration will unlock new avenues of value creation. By aligning product development with rigorous clinical evidence, optimizing supply chains against tariff headwinds, and tailoring strategies to distinct patient and regional profiles, stakeholders can establish competitive advantage and drive meaningful improvements in patient health.

As the landscape continues to evolve, a relentless focus on data interoperability, personalized nutrition, and adaptive care models will define market leaders. Ultimately, the most successful organizations will balance scientific excellence with operational agility, ensuring that every intervention empowers patients to swallow safely and live better lives.

Market Segmentation & Coverage

This research report categorizes the Dysphagia Management Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Feeding Tubes
    • Gastrostomy Tubes
    • Nasogastric Tubes
  • Soft Foods
    • Mechanical Soft Diets
    • Purees
  • Thickening Agents
    • Powdered Thickeners
      • Gum-Based
      • Starch-Based
    • Ready-To-Drink Thickeners
  • Adults
  • Geriatrics
    • Elderly Dependent
    • Elderly Independent
  • Pediatrics
    • Infants
    • Teenagers
  • Mechanical Dysphagia
    • Cancer-Related
    • Post-Surgical
  • Neurological Dysphagia
    • Dementia-Related
    • Stroke-Related
  • Home Healthcare Settings
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Long-Term Care Facilities
    • Nursing Homes
    • Rehabilitation Centers
  • Compensatory Techniques
    • Bolus Control
    • Posture Modifications
  • Restorative Techniques
    • Sensory Stimulation
    • Swallowing Exercises
  • Hospital Pharmacies
  • Online Sales
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Digital Therapeutics
    • Mobile Applications
    • Wearable Devices
  • Non-Digital Devices
    • Manual Swallow Aids

This research report categorizes the Dysphagia Management Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dysphagia Management Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Bracco Diagnostics Inc.
  • Cipla Limited
  • Cook Group Incorporated
  • Danone S.A.
  • Deosen Biochemical (Ordos) Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eisia Co.Ltd.
  • F. Hoffmann-La Roche AG
  • Flavour Creations
  • Fresenius Kabi AG
  • Hormel Foods Corporation
  • Ingredion Incorporated
  • International Flavors & Fragrances Inc.
  • Johnson & Johnson Services, Inc.
  • Kent Precision Foods Group, Inc.
  • Medline Industries, LP
  • Nestlé S.A.
  • Novartis AG
  • Phagenesis Ltd.
  • Rosemont Pharmaceuticals Limited
  • Slo Drinks
  • VitalStim UK Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dysphagia Management Market, by Product Type
8.1. Introduction
8.2. Feeding Tubes
8.2.1. Gastrostomy Tubes
8.2.2. Nasogastric Tubes
8.3. Soft Foods
8.3.1. Mechanical Soft Diets
8.3.2. Purees
8.4. Thickening Agents
8.4.1. Powdered Thickeners
8.4.1.1. Gum-Based
8.4.1.2. Starch-Based
8.4.2. Ready-To-Drink Thickeners
9. Dysphagia Management Market, by Patient Age Group
9.1. Introduction
9.2. Adults
9.3. Geriatrics
9.3.1. Elderly Dependent
9.3.2. Elderly Independent
9.4. Pediatrics
9.4.1. Infants
9.4.2. Teenagers
10. Dysphagia Management Market, by Disease Type
10.1. Introduction
10.2. Mechanical Dysphagia
10.2.1. Cancer-Related
10.2.2. Post-Surgical
10.3. Neurological Dysphagia
10.3.1. Dementia-Related
10.3.2. Stroke-Related
11. Dysphagia Management Market, by End User
11.1. Introduction
11.2. Home Healthcare Settings
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Long-Term Care Facilities
11.4.1. Nursing Homes
11.4.2. Rehabilitation Centers
12. Dysphagia Management Market, by Therapeutic Approach
12.1. Introduction
12.2. Compensatory Techniques
12.2.1. Bolus Control
12.2.2. Posture Modifications
12.3. Restorative Techniques
12.3.1. Sensory Stimulation
12.3.2. Swallowing Exercises
13. Dysphagia Management Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Sales
13.4. Retail Pharmacies
13.4.1. Chain Pharmacies
13.4.2. Independent Pharmacies
14. Dysphagia Management Market, by Technology Integration
14.1. Introduction
14.2. Digital Therapeutics
14.2.1. Mobile Applications
14.2.2. Wearable Devices
14.3. Non-Digital Devices
14.3.1. Manual Swallow Aids
15. Americas Dysphagia Management Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Dysphagia Management Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Dysphagia Management Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. AstraZeneca PLC
18.3.3. Becton, Dickinson and Company
18.3.4. Bracco Diagnostics Inc.
18.3.5. Cipla Limited
18.3.6. Cook Group Incorporated
18.3.7. Danone S.A.
18.3.8. Deosen Biochemical (Ordos) Ltd.
18.3.9. Dr. Reddy's Laboratories Ltd.
18.3.10. Eisia Co.Ltd.
18.3.11. F. Hoffmann-La Roche AG
18.3.12. Flavour Creations
18.3.13. Fresenius Kabi AG
18.3.14. Hormel Foods Corporation
18.3.15. Ingredion Incorporated
18.3.16. International Flavors & Fragrances Inc.
18.3.17. Johnson & Johnson Services, Inc.
18.3.18. Kent Precision Foods Group, Inc.
18.3.19. Medline Industries, LP
18.3.20. Nestlé S.A.
18.3.21. Novartis AG
18.3.22. Phagenesis Ltd.
18.3.23. Rosemont Pharmaceuticals Limited
18.3.24. Slo Drinks
18.3.25. VitalStim UK Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. DYSPHAGIA MANAGEMENT MARKET MULTI-CURRENCY
FIGURE 2. DYSPHAGIA MANAGEMENT MARKET MULTI-LANGUAGE
FIGURE 3. DYSPHAGIA MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. DYSPHAGIA MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. DYSPHAGIA MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DYSPHAGIA MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY GASTROSTOMY TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NASOGASTRIC TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL SOFT DIETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PUREES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY GUM-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY STARCH-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY READY-TO-DRINK THICKENERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY ELDERLY DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY ELDERLY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY CANCER-RELATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY POST-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DEMENTIA-RELATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY STROKE-RELATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY BOLUS CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY POSTURE MODIFICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY SENSORY STIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY SWALLOWING EXERCISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MANUAL SWALLOW AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 142. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 144. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 145. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 146. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 147. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 149. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 150. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 151. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 152. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 153. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 155. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 156. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 157. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 158. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 159. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 162. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 163. CANADA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 174. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 175. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 178. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 179. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 180. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 184. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES DYSPHAGIA MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC DYSPHAGIA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 254. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 256. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 257. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 258. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 259. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 261. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 262. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 263. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 264. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 265. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 268. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 269. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 270. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 271. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 273. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 274. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 275. CHINA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 276. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 278. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 279. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 280. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 281. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 282. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 283. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 284. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 286. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 287. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 290. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 291. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 292. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 293. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 295. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 296. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 297. INDIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 302. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 304. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 305. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 306. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY MECHANICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NEUROLOGICAL DYSPHAGIA, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY LONG-TERM CARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY THERAPEUTIC APPROACH, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY COMPENSATORY TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RESTORATIVE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA DYSPHAGIA MANAGEMENT MARKET SIZE, BY NON-DIGITAL DEVICES, 2018-2030 (USD MILLION)
TABLE 320. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY FEEDING TUBES, 2018-2030 (USD MILLION)
TABLE 322. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY SOFT FOODS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY THICKENING AGENTS, 2018-2030 (USD MILLION)
TABLE 324. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY POWDERED THICKENERS, 2018-2030 (USD MILLION)
TABLE 325. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 326. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY GERIATRICS, 2018-2030 (USD MILLION)
TABLE 327. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 328. JAPAN DYSPHAGIA MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 329. JAPAN DYSPHA

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Bracco Diagnostics Inc.
  • Cipla Limited
  • Cook Group Incorporated
  • Danone S.A.
  • Deosen Biochemical (Ordos) Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eisia Co.Ltd.
  • F. Hoffmann-La Roche AG
  • Flavour Creations
  • Fresenius Kabi AG
  • Hormel Foods Corporation
  • Ingredion Incorporated
  • International Flavors & Fragrances Inc.
  • Johnson & Johnson Services, Inc.
  • Kent Precision Foods Group, Inc.
  • Medline Industries, LP
  • Nestlé S.A.
  • Novartis AG
  • Phagenesis Ltd.
  • Rosemont Pharmaceuticals Limited
  • Slo Drinks
  • VitalStim UK Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dysphagia Management Market Report 2025 - Product Image

Dysphagia Management Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Dysphagia Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dysphagia Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Esophageal Dysphagia Market Report 2025 - Product Image

Esophageal Dysphagia Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Eosinophilic Esophagitis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 169 Pages
  • Global
From
Gastroparesis. Pathophysiology, Clinical Presentation, Diagnosis and Treatment - Product Image

Gastroparesis. Pathophysiology, Clinical Presentation, Diagnosis and Treatment

  • Book

About the Dysphagia Management Market

Dysphagia Management is a sub-sector of Gastrointestinal Drugs that focuses on the diagnosis and treatment of swallowing disorders. Dysphagia is a condition that affects the ability to swallow food and liquids, and can be caused by a variety of medical conditions. Dysphagia Management involves the use of medications, diet modifications, and other therapies to improve swallowing function. Treatment options may include medications to reduce muscle spasms, diet modifications to reduce the risk of aspiration, and physical therapy to improve swallowing coordination. The Dysphagia Management market is comprised of pharmaceutical companies, medical device manufacturers, and healthcare providers. Companies in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.